Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,962.00p
   
  • Change Today:
    -35.00p
  • 52 Week High: 2,340.00
  • 52 Week Low: 1,772.00
  • Currency: UK Pounds
  • Shares Issued: 234.72m
  • Volume: 192,559
  • Market Cap: £4,605.20m
  • RiskGrade: 125

Latest ShareCast News

Broker tips: Kingfisher, Accesso, Hikma

By Michele Maatouk

Date: Tuesday 20 May 2025

(Sharecast News) - Barclays downgraded its stance on B&Q and Castorama owner Kingfisher on Tuesday to 'underweight' from 'equalweight' as it said the more than 25% year-to-date total shareholder return was "overly generous".

RBC Capital ups price target on Hikma

By Abigail Townsend

Date: Tuesday 20 May 2025

(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.

Hikma surges as investors welcome medium-term guidance

By Michele Maatouk

Date: Thursday 15 May 2025

(Sharecast News) - Shares in Hikma Pharmaceuticals surged on Thursday as investors welcomed new medium-term guidance from the company.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,962.00p
Change Today -35.00p
% Change -1.75 %
52 Week High 2,340.00
52 Week Low 1,772.00
Volume 192,559
Shares Issued 234.72m
Market Cap £4,605.20m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
89.44% below the market average89.44% below the market average89.44% below the market average89.44% below the market average89.44% below the market average
47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average47.83% below the sector average
Price Trend
15.36% above the market average15.36% above the market average15.36% above the market average15.36% above the market average15.36% above the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average
Income
3.59% above the market average3.59% above the market average3.59% above the market average3.59% above the market average3.59% above the market average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average
Growth
37.53% above the market average37.53% above the market average37.53% above the market average37.53% above the market average37.53% above the market average
18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average18.75% above the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 3
Sell 0
Strong Sell 0
Total 12
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 20-Mar-25 15-Aug-24
Paid 01-May-25 20-Sep-24
Amount 48.00¢ 32.00¢

Trades for 11-Jul-2025

Time Volume / Share Price
16:04 0 @ 1,966.00p
16:04 0 @ 1,966.00p
16:04 0 @ 1,966.00p
16:04 0 @ 1,966.00p
16:04 0 @ 1,966.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page